(S)-1-(4-Methoxypyridin-2-yl)ethanamine dihydrochloride, 98%, 250mg

Fmoc-Inp-OH, 95%, 1g

2-Hydroxy-4-phenyl-pyrimidine-5-carboxylic acid ethyl ester, 95.0%, 1g

1-(4-Bromo-2-methylphenyl)piperidine, 97%, 1g

(2S,3S)-METHYL 3-HYDROXYPYRROLIDINE-2-CARBOXYLATE HCL, 95.0%, 100mg

1-Isobutyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid, 97%, 250mg

5-Ethoxycarbonylamino-[1,2,3]thiadiazole-4-carboxylic acid ethyl ester, 95.0%, 5g

3-Bromo-2-chloro-4-methoxypyridine, 95.0%, 5g

Matraz receptor con revestimiento de PUR, 1000 ml, 1 pieza

2-(2-Phenylethyl)-1,3-thiazole-4-carboxylic acid, 97%, 100mg

2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride, 95.0%, 1g

5ALPHA-CHOLESTANE, 97%, 100mg

5-(3,4-dimethylphenyl)-1H-pyrazole, 95.0%, 2g